Shaking off shingles with nanoviricides

NanoViricides, Inc. has developed unique micelles termed nanoviricides that can bind and inactivate viruses, including those that cause shingles and genital ulcers.

Like Comment
Page of
Go to the profile of NanoViricides


NanoViricides, Inc. is a development stage company with a unique nanomedicine technology. The Company is developing nanotechnology-based biomimetic anti-viral medicines, that we call "nanoviricides®". Virus-specific nanoviricide drug candidates against five commercially important viral diseases, viz. seasonal and potentially-epidemic influenzas and bird flu, HIV/AIDS, cold sores and genital herpes infection, viral eye diseases, as well as dengue viruses, have demonstrated very high levels of effectiveness.

No comments yet.